Belgian company Syndesi Therapeutics was backed by Irish VC Fountain Healthcare on spin-out
Fountain Healthcare
Neuromod welcomes independent real-world study confirming clinical trial data
Company completes dosing in first round of trial of treatment for coeliac disease
Funding will drive commercialisation of Reactiv8 in critical US market
Galway-based Neurent looks to capitalise on treatment for one of the most common chronic conditions
Galway medical device group sees $2bn market for novel rhinitis device
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Large-scale trial shows improvement after 12 weeks, sustained results after 12 months
Cantillon: Venture capital business sells Inflazome to Roche for €380m
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times